Abstract
Background: The prevalence of metastatic bone disease (MBD) grows each year as treatments improve. Little has been published about functional and pain outcomes in this group after surgery. Patient-Reported Outcomes Measurement Information System (PROMIS®) can collect information, in just minutes, about patient's physical, mental, and social health. This study evaluated PROMIS® pain and functional scores in surgically treated patients with MBD. Methods: Basic demographics and PROMIS® scores were recorded from a total of 13 patients at 9 periods of time over 6 months. Results: The average change in physical function at week 1 was −2.5 (standard deviation [SD] = 5.4), at 2 weeks 1.7 (SD = 7.6), after 4 weeks 6.9 (SD = 10), after 6 weeks 6.4 (SD = 10.9), after 10 weeks 15.3 (SD = 3.1), and after 3 months 8.6 (SD = 7.6). The average change in pain inference at week 1 was −1.2 (SD = 7.3), at 2 weeks −2.1 (SD = 9.5), after 4 weeks −12.6 (SD = 4.5), after 6 weeks −8.3 (SD = 10.2), after 10 weeks −16.6 (SD = 4.3), and after 3 months −11.4 (SD = 8.2). Conclusions: PROMIS® provides a feasible means to collect data in this population. Trends of improved function and decreased pain were seen after surgery. Continuing this study will hopefully elucidate more insight into the surgical treatment of MBD.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 532-535 |
| Number of pages | 4 |
| Journal | Journal of Surgical Oncology |
| Volume | 118 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 1 2018 |
Fingerprint
Keywords
- functional outcomes
- metastatic bone disease (MBD)
ASJC Scopus subject areas
- Surgery
- Oncology
Cite this
PROMIS® scores in operative metastatic bone disease patients : A multicenter, prospective study. / Blank, Alan T.; Lerman, Daniel M.; Shaw, Sara; Dadrass, Farnaz; Zhang, Yue; Liu, Wei; Hung, Man; Jones, Kevin B.; Randall, R.
In: Journal of Surgical Oncology, Vol. 118, No. 3, 01.09.2018, p. 532-535.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - PROMIS® scores in operative metastatic bone disease patients
T2 - A multicenter, prospective study
AU - Blank, Alan T.
AU - Lerman, Daniel M.
AU - Shaw, Sara
AU - Dadrass, Farnaz
AU - Zhang, Yue
AU - Liu, Wei
AU - Hung, Man
AU - Jones, Kevin B.
AU - Randall, R
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Background: The prevalence of metastatic bone disease (MBD) grows each year as treatments improve. Little has been published about functional and pain outcomes in this group after surgery. Patient-Reported Outcomes Measurement Information System (PROMIS®) can collect information, in just minutes, about patient's physical, mental, and social health. This study evaluated PROMIS® pain and functional scores in surgically treated patients with MBD. Methods: Basic demographics and PROMIS® scores were recorded from a total of 13 patients at 9 periods of time over 6 months. Results: The average change in physical function at week 1 was −2.5 (standard deviation [SD] = 5.4), at 2 weeks 1.7 (SD = 7.6), after 4 weeks 6.9 (SD = 10), after 6 weeks 6.4 (SD = 10.9), after 10 weeks 15.3 (SD = 3.1), and after 3 months 8.6 (SD = 7.6). The average change in pain inference at week 1 was −1.2 (SD = 7.3), at 2 weeks −2.1 (SD = 9.5), after 4 weeks −12.6 (SD = 4.5), after 6 weeks −8.3 (SD = 10.2), after 10 weeks −16.6 (SD = 4.3), and after 3 months −11.4 (SD = 8.2). Conclusions: PROMIS® provides a feasible means to collect data in this population. Trends of improved function and decreased pain were seen after surgery. Continuing this study will hopefully elucidate more insight into the surgical treatment of MBD.
AB - Background: The prevalence of metastatic bone disease (MBD) grows each year as treatments improve. Little has been published about functional and pain outcomes in this group after surgery. Patient-Reported Outcomes Measurement Information System (PROMIS®) can collect information, in just minutes, about patient's physical, mental, and social health. This study evaluated PROMIS® pain and functional scores in surgically treated patients with MBD. Methods: Basic demographics and PROMIS® scores were recorded from a total of 13 patients at 9 periods of time over 6 months. Results: The average change in physical function at week 1 was −2.5 (standard deviation [SD] = 5.4), at 2 weeks 1.7 (SD = 7.6), after 4 weeks 6.9 (SD = 10), after 6 weeks 6.4 (SD = 10.9), after 10 weeks 15.3 (SD = 3.1), and after 3 months 8.6 (SD = 7.6). The average change in pain inference at week 1 was −1.2 (SD = 7.3), at 2 weeks −2.1 (SD = 9.5), after 4 weeks −12.6 (SD = 4.5), after 6 weeks −8.3 (SD = 10.2), after 10 weeks −16.6 (SD = 4.3), and after 3 months −11.4 (SD = 8.2). Conclusions: PROMIS® provides a feasible means to collect data in this population. Trends of improved function and decreased pain were seen after surgery. Continuing this study will hopefully elucidate more insight into the surgical treatment of MBD.
KW - functional outcomes
KW - metastatic bone disease (MBD)
UR - http://www.scopus.com/inward/record.url?scp=85052664792&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052664792&partnerID=8YFLogxK
U2 - 10.1002/jso.25159
DO - 10.1002/jso.25159
M3 - Article
C2 - 30114336
AN - SCOPUS:85052664792
VL - 118
SP - 532
EP - 535
JO - Journal of Surgical Oncology
JF - Journal of Surgical Oncology
SN - 0022-4790
IS - 3
ER -